BioCryst Pharmaceuticals | BCRX - Loan Capital


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

BioCryst Pharmaceuticals

BioCryst Pharmaceuticals reported $733.28M in Loan Capital for its fiscal quarter ending in December of 2022.


Loan Capital Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 945K
Daiichi Sankyo 4568:JP JPY 101.69B 94M
Enanta Pharmaceuticals ENTA:US USD 1.42M 0
Glaxosmithkline GSK:US GBP 16.64B 391M
GlaxoSmithKline GSK:LN GBP 16.64B 391M
Incyte Corp INCY:US USD 29.7M 384K
Ionis Pharmaceuticals IONS:US USD 1.18B 1.66M
Karyopharm Therapeutics KPTI:US USD 303.02M 201K
Novavax NVAX:US USD 197.85M 146K
PTC Therapeutics PTCT:US USD 1.25B 21.18M
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Roche Holding ROG:VX CHF 21.39B 978M
Sarepta Therapeutics SRPT:US USD 1.23B 310.01M
Vertex Pharmaceuticals VRTX:US USD 417.6M 13.2M